Immunic Inc. (IMUX)
Immunic Statistics
Share Statistics
Immunic has 90.15M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 90.15M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 50.44% |
| Shares Floating | 87.43M |
| Failed to Deliver (FTD) Shares | 635 |
| FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 3.52M, so 3.91% of the outstanding shares have been sold short.
| Short Interest | 3.52M |
| Short % of Shares Out | 3.91% |
| Short % of Float | 4.03% |
| Short Ratio (days to cover) | 3.76 |
Valuation Ratios
The PE ratio is -1 and the forward PE ratio is -1.29. Immunic's PEG ratio is 0.02.
| PE Ratio | -1 |
| Forward PE | -1.29 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 5.44 |
| P/FCF Ratio | -1.18 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Immunic.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.77 |
| Quick Ratio | 1.77 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.18M |
| Employee Count | 85 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -15.45% in the last 52 weeks. The beta is 1.9, so Immunic's price volatility has been higher than the market average.
| Beta | 1.9 |
| 52-Week Price Change | -15.45% |
| 50-Day Moving Average | 1.09 |
| 200-Day Moving Average | 1.25 |
| Relative Strength Index (RSI) | 42.22 |
| Average Volume (20 Days) | 843.83K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -98.05M |
| Net Income | -100.51M |
| EBITDA | -98.05M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1 |
Balance Sheet
The company has 35.67M in cash and 264K in debt, giving a net cash position of 35.4M.
| Cash & Cash Equivalents | 35.67M |
| Total Debt | 264K |
| Net Cash | 35.4M |
| Retained Earnings | -511.4M |
| Total Assets | 64.76M |
| Working Capital | 39.91M |
Cash Flow
In the last 12 months, operating cash flow was -84.77M and capital expenditures -264K, giving a free cash flow of -85.03M.
| Operating Cash Flow | -84.77M |
| Capital Expenditures | -264K |
| Free Cash Flow | -85.03M |
| FCF Per Share | -0.85 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IMUX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for IMUX is $10, which is 861.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 861.5% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on Apr 15, 2019. It was a backward split with a ratio of 1:40.
| Last Split Date | Apr 15, 2019 |
| Split Type | backward |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | -12.21 |
| Piotroski F-Score | 1 |